RMAX · Re/Max Holdings, Inc. · Stock research

ns# RMAX — RE/MAX Holdings, Inc.

Current Thesis

The last named condition cleared. On 2026-08-21 RE/MAX filed an 8-K disclosing that the Supreme Court of British Columbia issued the final order approving the arrangement, and both parties said they expect to complete on 2026-08-24. New York time on 2026-08-24, and Real REMAX Group shares are expected to open on Nasdaq as REAX under new CUSIP 776105108 on 2026-08-25.

The spread finished converging into that. RMAX closed $13.62 on 2026-08-21; REAX closed $2.64 the same session (down 4.00% on the day). At the fixed 5.150 exchange ratio the stock leg marks $13.60. There is no arb left to collect — the listed line is now a one-session proxy on REAX with a delisting attached.

The election also resolved. By the 5:00 p.m. ET 2026-08-18 deadline, holders of 18,488,134 Class A shares elected cash, which exceeded the $80 million Available Maximum Aggregate Cash Amount. Under proration, each cash-electing share is expected to receive approximately $4.33 in cash plus approximately 0.3535 post-consolidation Real REMAX shares; everything else takes the stock election. Against a full stock election of ~0.515 post-consolidation shares, the two packages land close to one another at REAX's 2026-08-21 level — the cash kicker that once justified RMAX trading through its stock leg has been scaled back to a fraction of the $13.80 headline.

Bullish and bearish views on Re/Max Holdings, Inc.

The model's bull view on Re/Max Holdings, Inc. (RMAX), in brief: Every condition the deal was tracking has been satisfied. The bear view: Nothing left converges. RMAX at $13.62 versus a $13.60 stock leg is parity. Remaining upside from here is entirely REAX's, and REAX fell 4.00% on 2026-08-21 alone. One session of unhedgeable acquirer beta. Every $0.10 on REAX moves the stock leg $0.515. REAX's 52-week range is… Both cases follow in full.

Bull Case

• Every condition the deal was tracking has been satisfied. DOJ early termination of the HSR waiting period on 2026-07-13; interim order 2026-07-06; both securityholder votes 2026-08-14 (Real ~99.0% of votes cast; RE/MAX 78.8% of voting power); final order 2026-08-21.
• The closing date is now a filed expectation, not guidance. The 2026-08-14 release said "the next couple of weeks"; the 2026-08-20 and 2026-08-21 releases both name 2026-08-24, with the consolidation time and the first Nasdaq trading day (2026-08-25) specified.
• Proration is quantified rather than unknown. The 2026-08-20 preliminary results give the cash-elect package as ~$4.33 plus ~0.3535 shares, removing the settlement uncertainty that sat in the price through mid-August.
• The acquirer's operating trend held into the close. Real Q2 2026 (reported week of 2026-08-06): revenue +30% y/y to $700.6M, adjusted EBITDA +38%. Pro forma the combination carries ~$2.3B of 2025 revenue and $157M adjusted EBITDA before synergies (2026-08-14 release).
• REAX has run from $1.68 (2026-06-07) to $2.64 (2026-08-21), and the stock leg has re-rated with it.

Bear Case

• Nothing left converges. RMAX at $13.62 versus a $13.60 stock leg is parity. Remaining upside from here is entirely REAX's, and REAX fell 4.00% on 2026-08-21 alone.
• One session of unhedgeable acquirer beta. Every $0.10 on REAX moves the stock leg $0.515. REAX's 52-week range is $1.55–$5.405; it printed $2.13 on 2026-08-08 and $2.64 on 2026-08-21.
• The cash election was scaled back hard. 18,488,134 shares chased a $80M pool; the resulting ~$4.33 per cash-electing share is a small share of the $13.80 cash election headline, and the definitive numbers can differ from the preliminary ones.
• Standalone economics did not improve. RMAX Q2 2026 on 2026-08-06: adjusted EPS $0.32 versus $0.39 consensus; revenue $68.510M versus $72.700M consensus. Both lines missed and the shares made new highs anyway because price tracked REAX and the ratio.
• The security terminates. RMAX Class A delists at the effective time; holders wake up in a Nasdaq line that has just done a 10-for-1 consolidation and changed CUSIP.
• A break, at this price, is a long fall. Pre-announcement trade was ~$6; the 52-week low is $5.46.

Setup & Price Structure

The narrative is saturated. The narrative — regulatory clearance, then votes, then court, then close — has been fully delivered and dated, and the discount that paid for holding it is gone. On 2026-07-15 the same structure carried a roughly 6.5% discount to the blended consideration; on 2026-08-21 the listed price sits within two cents of the stock leg.

Observable crowding and extension, as of the 2026-08-21 close:

• RSI(14) at 86.9, with the shares up 45.2% over three months and 5.5% below the $14.41 52-week high.
• 2026-08-18: Benzinga ran RMAX in a "real estate stocks that may keep you up at night" high-RSI momentum screen alongside CMCT and CLPR — retail-facing coverage arriving after the move, not before it.
• 18,488,134 Class A shares elected cash by 2026-08-18, a heavy tilt toward the certain leg from a holder base that has largely turned over to event money.
• No earnings date ahead: Q2 was 2026-08-06 and there is no Q3 print for this security.

There is no technical structure worth naming here — the chart is the exchange ratio times REAX, and it stops on 2026-08-24.

Catalyst Calendar (next 30 days)

• ~2026-08-25 to 2026-09-05 (est.) — Form 25 delisting notice for RMAX Class A and index-provider deletion notices; mechanical flows around the effective date.

Elapsed catalysts

• 2026-08-24 — Closing / effective time. ET; RMAX Class A ceases trading and converts. (passed 2d ago)
• ~2026-08-24 (est.) — Definitive election and proration results superseding the preliminary ~$4.33 cash / ~0.3535 shares per cash-electing share. (passed 2d ago)
• 2026-08-25 — Real REMAX Group expected to begin trading on Nasdaq as REAX under CUSIP 776105108 at the open. (passed 1d ago)

What Would Change Our Mind

The structural break is timing, and it is now narrow: 2026-08-24 passing with no completion announcement and no replacement date would reopen a completion risk the market has priced at essentially zero, after the court has already signed. A second break is the definitive proration coming back materially different from the ~$4.33 / ~0.3535 preliminary split, which would reprice the cash leg at settlement for the 18,488,134 shares that elected it.

On price, a daily close below $12.36 — the 2026-08-14 stock-leg mark at the 5.150 ratio when REAX was $2.40 — would mean REAX has given back the August move or that completion doubt has re-entered; below that, the pre-announcement ~$6 area and the $5.46 52-week low are the relevant references, not the deal terms.

What would not change the read: another weak standalone RE/MAX datapoint. The 2026-08-06 miss on both lines moved nothing, because the ratio, not the franchisor's P&L, sets the price.

Correlation Notes

• REAX is the position. At 5.150 pre-consolidation shares per RMAX share (~0.515 post), RMAX's daily return is REAX's daily return net of a residual cash-election component. The 2026-08-21 pairing — REAX $2.64, RMAX $13.62, stock leg $13.60 — leaves no cushion between them.
• Post-close, the exposure is a Nasdaq-listed brokerage roll-up, not an NYSE franchisor: ~$2.3B pro forma 2025 revenue, 180,000+ agents in 120+ countries, with the operating sensitivity of transaction volumes and agent-count churn rather than franchise fees.
• The 2026-08-18 momentum screen grouping with CMCT and CLPR is a screen artifact. RMAX's move came from an exchange ratio and a court date; those two are unrelated real-estate names caught by the same RSI filter.
• Rate-sensitivity re-enters after closing. RMAX's price has been decoupled from mortgage-rate news since the April announcement; the surviving entity trades on residential transaction volumes with peers such as COMP, EXPI and ZG.